News
Rescuers on Saturday recovered one more body from the wreckage of Air India Flight AI-171 that crashed shortly after taking ...
Like any other new technological trend, robotic mowers prompt questions from potential adopters, and some specific, ...
BMO Capital Markets reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY), setting a price target of $900 ...
Major players including AbbVie, GSK, Sanofi, and Eli Lilly recently bolstered their R&D pipelines with a wave of acquisitions ...
Novartis launched a tender offer for Regulus Therapeutics. Biogen and City Therapeutics announced a partnership to develop a drug for an undisclosed central nervous system disease. Eli Lilly bought ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
LLY to acquire SiteOne for up to $1 billion. GSK's antibiotic study ends early for efficacy. MRNA loses H5 flu vaccine funding, while SNY sees mixed COPD data.
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
If approved by regulators, the acquisition would give Lilly strategic access to STC-004, an experimental non-opioid pain ...
US pharma major Eli Lilly (NYSE: LLY) has announced a definitive agreement to acquire SiteOne Therapeutics, a private biotechnology company developing small molecule inhibitors of sodium channels to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results